Loading…
Loading…
The moves that matter — curated from across forex, stocks and crypto, and readable in full right here.
Updated 3 Sept, 01:30 am
Rocket Lab (NASDAQ: RKLB) is strategically expanding its business model beyond launch services to include the development and manufacturing of diverse spacecraft components, targeting both commercial and government clients. Despite recent stock declines and competitive pressures,
Analyst firm William Blair upgraded GitLab's stock to " Market Perform " after strong second-quarter financial results. GitLab exceeded analyst expectations with an EPS of $0.24 and quarterly revenue of $286.25 million . The company demonstrated robust customer growth, with custo
Analyst firm Bernstein reaffirmed its " Outperform " rating for Palo Alto Networks, signaling confidence in the cybersecurity leader. The company demonstrated robust financial health with record remaining performance obligations (RPO) and significant growth in Next-Generation Sec
Strong Earnings Beat: GitLab reported an earnings per share (EPS) of $0.24 , significantly beating the analyst estimate of $0.18 , leading to a 33.33% earnings surprise and a 15% stock surge. Robust Revenue Growth: Quarterly revenue reached $286.25 million , surpassing estimates
Despite mixed analyst ratings, including a price target reduction from Goldman Sachs and a downgrade from UBS, Interactive Brokers (NASDAQ:IBKR) continues to show strong market confidence with a potential upside of 25% from its trading price at the time of the Goldman Sachs annou
Rezolve AI (NASDAQ: RZLV) Reports Rapid Revenue Growth as Losses Widen Rezolve AI (NASDAQ: RZLV) reported first-half revenue of $130.8 million , an increase of approximately 1,970% from the previous year. The company posted an EPS loss of $0.35 , compared with the estimated loss
Vertex Pharmaceuticals received an "Overweight" rating from Morgan Stanley, with a price target of $665 , indicating strong analyst confidence in the biotech stock . The company is strategically diversifying its pharmaceutical pipeline beyond cystic fibrosis treatments through ac
Credo Technology Group Holding Ltd. (NASDAQ:CRDO) exceeded earnings expectations with an EPS of $1.20 , beating the Zacks Consensus Estimate by 2.56% . The company reported robust revenue of approximately $479 million , surpassing estimates and marking a substantial 114.7% year-o
Alliance Global Sets $217 Price Target for Strategy Inc. (NASDAQ: MSTR) Strategy Inc.’s stock performance remains closely connected to Bitcoin because of the company’s substantial cryptocurrency holdings and Bitcoin-focused capital strategy. Alliance Global Partners i
Investment firm Goldman Sachs has upgraded its rating on Deutsche Bank to "Buy" from "Neutral," signaling a positive shift in its investment outlook . This upgrade aligns with Deutsche Bank's announcement of a new €500 million ($583.35 million) share buyback program , a move ofte
MongoDB reported strong earnings per share of $1.90 , significantly surpassing analyst estimates of $1.62 . The company achieved robust revenue of $771.77 million , marking a 30% increase year-over-year and exceeding forecasts. From a financial health perspective, MongoDB maintai
Alumis (NASDAQ: ALMS) experienced a significant stock drop following the failure of its Phase II lupus drug trial. Despite the overall trial setback, positive results in a specific patient subgroup offer a potential path for future drug development for the biotechnology firm . Th
Partners Group Holding AG (OTC: PGPHF) Reports Lower H1 Profit and Leadership Transition Partners Group Holding AG (OTC: PGPHF) reported first-half 2026 revenue of CHF 1.12 billion , down 7% year over year . Net profit declined 13% to CHF 502 million , while basic earnings per sh
Alarum Technologies Ltd. is set to release its Q3 earnings, with analysts forecasting an EPS of $0.02 on $12.2 million in revenue. The company is embroiled in a class action lawsuit, alleging its NetNut subsidiary was involved in malicious online traffic, with a lead plaintiff de
Top Market Gainers: SPAC Volatility, Biotech, Geothermal Energy, and AI Stocks Rally Rising Dragon Acquisition Corp. (NASDAQ: RDAC) surged amid continued volatility in the low-float SPAC. bioAffinity Technologies Inc. (NASDAQ: BIAF) advanced sharply following its recent reverse s
Market Downturn: Alumis (NASDAQ: ALMS) Plunges on Trial Results, Enovis (NYSE: ENOV) Falls After Acquisition Offer, and Leveraged ETFs Decline Alumis Inc. (NASDAQ: ALMS) plunged after its Phase 2b LUMUS trial of envudeucitinib failed to meet its primary and secondary endpoints. E
Enovis (NYSE: ENOV) received a revised price target of $27.00 from BMO Capital, suggesting a 24.6% upside despite a recent stock dip. The medical technology company is strategically expanding into surgical robotics through a binding offer to acquire eCential Robotics. This acquis
Citigroup Reaffirms Buy Rating on NIO (NYSE: NIO) Despite Lower Price Target Citigroup reiterated its “ Buy ” rating on NIO but lowered its price target to $7.10 from $8.20 . NIO’s second-quarter deliveries and revenue fell below the company’s guidance, wh
Headlines provided by Investing.com